Microbial Resistance to Antibiotics - PowerPoint PPT Presentation

1 / 63
About This Presentation
Title:

Microbial Resistance to Antibiotics

Description:

Not themselves mobile, but excise and integrate cassettes that are ... Cassettes for b-lactamases, aminoglycoside resistance, chloramphenicol ... – PowerPoint PPT presentation

Number of Views:181
Avg rating:3.0/5.0
Slides: 64
Provided by: microbio7
Category:

less

Transcript and Presenter's Notes

Title: Microbial Resistance to Antibiotics


1
Microbial Resistance to Antibiotics
Henry F. Chambers, M.D. Professor of Medicine
2
Most Important Infectious Agents on the Planet
  • Mycobacterium tuberculosis
  • Plasmodium falciparum
  • Human immunodeficiency virus

3
Most Common Bacterial Pathogens on the Planet
  • Mycobacterium tuberculosis
  • Enterics (Salmonella enterica, Shigella sp., E.
    coli)
  • Staphylococcus aureus
  • Streptococcus sp. (S. pneumoniae, S. pyogenes)
  • Neisseria sp. (N. gonorrhoeae, N. meningitidis)
  • Hemophilus sp.

4
Resistance is relative, depending on .
  • The host and the site of infection
  • The intrinsic activity of the drug and its
    achievable concentration in the host
  • The level of susceptibility exhibited by the
    microorganism at the site of infection

5
Selective Pressure
Low fitness cost or compensated
Resistance
High fitness cost
Ton-Days of Antibiotics
6
Compensatory Mutations
  • Wild-type is best adapted, most fit
  • Mutation (or acquisition of resistance genes)
    comes at a cost
  • Cost can be compensated by
  • loss of resistance (by reversion or
    recombination)
  • by compensatory mutations
  • Compensatory mutations are
  • environmentally determined
  • a consequence of a low recombination rate

7
Example of Compensatory Mutations
  • Salmonella typhimurium LT2
  • SmR resistant to streptomycin (ribosomal
    inhibitor)
  • Cost slow growth because of reduced rate of
    protein synthesis
  • SmR passaged in broth (LB) and mice
  • Mutants recovering fitness (fast growth) analyzed
    for acquisition of compensatory mutations

Bjorkman, Science 287479 (2000)
8
Compensatory Mutations
Bjorkman, Science 287479 (2000)
Salmonella typhimurium LT2
9
Relative Fitness of SmR Mutants
Bjorkman, Science 287479 (2000)
10
Resistant Strain Passaged w/o Antibiotic Pressure
Types of Mutations
Bjorkman, Science 287479 (2000)
11
Effect of Bottleneck on Emergence of Compensatory
Mutations
Levin, Genetics 154985, 2000
12
Compensatory Mutations
  • Favored when the rate of their generation exceeds
    reversion
  • Bottlenecks play an important role
  • Function to maintain resistance (implications for
    antibiotic control)
  • Less likely to occur if gene exchange or
    recombination is common

13
General Types of Resistance
  • Extrinsic resistance
  • Gram-neg. cocci
  • Staphylococci
  • Streptococci
  • E. coli
  • Intrinsic resistance
  • M. tuberculosis
  • Pseudomonas
  • Enterococci

14
Biochemistry of Resistance
  • Antibiotic is not in an active (e.g., hydrolyzed,
    modified)
  • Antibiotic does not reach its target (fails to
    penetrate a membrane, efflux pump)
  • Target is changed, modified

15
Genetics of Resistance
  • Vertical, mutation and selection
  • Fluoroquinolone resistance in all bacterial
    species
  • All drug resistance in Mtb
  • Comparatively less advantageous
  • Horizontal, transfer of mobile element and
    selection
  • Transducing phage (e.g., transfer of S. aureus
    bla plasmid)
  • Transformation, homologous recombination (e.g.,
    penicillin-resistance in pneumococci)
  • Conjugation (e.g., vanA resistance of
    enterococci)
  • Comparatively more advantageous

16
Mycobacterium tuberculosis A Paradigm of
Mutation-selection Mediated Resistance
17
Drug Resistance in Mycobacterium tuberculosis
  • MTB infects 1/3 of the worlds population
  • About 10-25 of strains are resistant to at least
    one drug depending on region of the world
  • Up to 10-20 resistant to isoniazid (INH) and
    rifampin (RIF), i.e., MDR
  • Important cause of treatment failure

18
Emergence of Resistance with Single Drug Therapy
of Active TB
Start INH alone
19
Resistant Subpopulations in MTB
20
Pathogenesis of Secondary Drug Resistance
Meanwhile, in the lab...
21
Molecular Basis of MDR TB
  • INH
  • High level resistance katG (catalase) mutations
    and deletions
  • Low level resistance inhA (mycolic acid
    synthetic enzyme) overexpression
  • Rifampin, rifabutin, rifapentine rpoB RNA
    polymerase target mutation

22
Molecular Basis of MDR TB
  • PZA pncA (pyrazinamidase/nicotinamidase), which
    activates PZA
  • Fluoroquinolones gyrA (gyrase) target
    alteration
  • Streptomycin rpsL (ribosomal protein S12) or
    rrs (16S rRNA), altered binding to the ribosome
  • Ethambutol point mutations in embCAB gene
    cluster (role in arabinoglycan synthesis)

23
What about Fitness?
  • High-level INH resistance is mediated by
    catalase-gene deletion or mutation at the cost of
    susceptibility to oxidative stress
  • Rifampin resistance is mediated by rpoB mutation,
    which is relatively cost neutral
  • MDR strains generate fewer secondary cases
  • But what about the W strain (Beijing)?

24
Resistance Mediated by Horizontal Transfer
25
Toxins and Mobile Elements
26
Mobile Elements Involved in Resistance
27
Resistance Integrons
28
Integrons
  • An integrase, gene cassette(s), and a cassette
    integration site (att), a strong promoter
  • Not themselves mobile, but excise and integrate
    cassettes that are
  • Found on transposons, plasmids, chromosome
  • Two major groups resistance integrons and
    super-integrons (presumed ancestor, 100 kb)

29
Integron Structural Features
30
Gene Cassettes
  • Open reading frame, usually promoterless
    (provided by integron)
  • A repeat sequence, attC, that is recognized by
    integrase
  • Cassettes for b-lactamases, aminoglycoside
    resistance, chloramphenicol resistance,
    trimethoprim resistance, ciprofloxacin, etc

31
(No Transcript)
32
(No Transcript)
33
(No Transcript)
34
Integrons - Epidemiology
  • Mainly found in gram-negatives, especially
    enterobacteriacae (but also M. fortuitum and E.
    faecalis)
  • Resistance integrons are interspecies
    transferrable
  • Link between integrons in agriculatural isolates
    and human isolates

35
Methicillin Resistance in Staphylococcus aureus
36
Beta-lactam Antibiotic Resistance of
Staphylococcus aureus
  • Inactivation penicillinase (blaZ)
  • Four types, relatively narrow spectrum
  • Usually plasmid encoded, inducible
  • Methicillin resistance target alteration
  • Low affinity transpeptidase, PBP 2a (mecA)
  • Inducible, chromosomal, found only in MRSA,
    foreign
  • Can substitute for other synthetic PBPs

37
(No Transcript)
38
Characteristics of Community MRSA
  • Associated with outbreaks, often in new
    populations (e.g., children, football players,
    MSM)
  • Specific clones, different from those typically
    found in hospitals
  • Susceptible to many antibiotics
  • SCCmec type IV
  • Toxin production (Panton-Valentine leukocidin,
    PVL)

39
(No Transcript)
40
(No Transcript)
41
Common MRSA Clones
Enright, PNAS 997687, 2002
42
Clonal Complexes of MRSA strains
Enright Fey Okuma
MN, MS, ND, TN Europe, Oceania, Australia
43
Molecular Epidemiology of CA-MRSAEmergence of
Common Clone USA300 (ST8)

100
80
60
Football Team X MRSA, Abscess
Football Team Y MRSA, Abscess
California College Football
Pennsylvania HS Football
Colorado Fencers
California MSM
Mississippi Prison
Texas Jail
Georgia Prison
Tennessee Children
Texas Children
Missouri Children
Football Team X MSSA, Nasal
USA300 Community
USA100 Hospital strain
USA200 Hospital strain
44
MRSA from Bay Area Patients, 2004-5
1 2 3 4 5 6 7 8
origin clone 1 ST
FRANCIS 1 ST8S1 2 ST FRANCIS 2
ST8S1 3 SFGH blood ST8S7 4 SFGH eye
ST8S7 5 SFGH eye ST8S1 6 UCSF eye
(HA) ST5D 7 UCSF eye ST8S1 8 MARIN CAP
ST8S1
Merl 261/2005
45
PVL as a Putative Virulence Factor
  • Hygiene and predisposing host conditions appear
    to influence CA-MRSA colonization
  • PVL implicated in skin and soft-tissue infections
  • May enhance spread by creating an easily
    contacted reservoir shedding large numbers of
    bacteria
  • Synergism with SCCmec ineffective antimicrobial
    therapy may prolong time of shedding

46
Vancomycin Resistance
47
Vancomycin
  • A glycopeptide, 1450 daltons
  • Inhibitor of cell wall synthesis
  • Target D-alanyl-D-alanine
  • Interferes with transglycosylation and
    transpeptidation (crosslinking) reactions
  • Bactericidal

48
Vancomycin Use United States
VISA
VRE
49
Outside cell
TG
TG transglycosylase
Inside cell
50
(No Transcript)
51
Players in vanA resistance
  • Enterococcus faecium and E. faecalis donors
  • A broad-host range conjugative plasmid
  • Suitable recipient cell (pheromone producer)
  • A transposon, Tn1546, resident on the plasmid
  • The D-ala-D-ala target

52
Map of Transposon Tn1546
53
racemase
Inside cell
L-ala
D-ala D-ala
D-ala D-ala L-lys D-glu L-ala NAM
D-ala D-ala L-lys D-glu L-ala NAM
L-lys D-glu L-ala NAM
ligase
D-ala D-ala
NAG-
NAG-
Pi
Pi
NAG
Outside cell
54
(No Transcript)
55
Outside cell
VanY
D-ala
TG
TG transglycosylase
Inside cell
56
(No Transcript)
57





O
O C
R__D-ala
C O
58
Enterococcus faecalis Conjugative Plasmid
Clewell, Plasmid 48193 (2002)
59
Some General Features of Conjugative Plasmids
  • Tend to be relatively large gt 50kb
  • A DNA transport system that combines elements of
  • A DNA rolling circle replication system
  • Type IV secretion system
  • Plasmid encoded features
  • Origin of transfer (oriT)
  • DNA replicating enzymes (e.g., helicase,
    relaxase, replicase)
  • Coupling proteins, transport proteins,
    aggregating proteins
  • Regulators of the pheromone response
    anti-pheromone

60
Model of DNA Transport by a Conjugative Plasmid
Llosa, Mol Microbiol 451, 2002
61
Vancomycin Resistant Staphylococcus aureus
  • Intermediate presumably due to false target
    overproduction MIC 8 mg/ml
  • vanA type three strains reported (MICs 16-1024
    mg/ml)
  • Presumed donor E. faecalis with a vanA encoding
    conjugative plasmid
  • Tn1546 present on a staphylococcal conjugative
    plasmid, which is transferable
  • A residual, nontransferable presumed enterococcal
    conjugative plasmid relic

62
Closing Comments
  • Given enough time and pressure, resistance will
    eventually occur
  • When possible acquisition of resistance (and
    probably other traits as well) occurs by
    horizontal gene transfer
  • Compensatory mutations are a way to mitigate the
    cost of resistance and maintain the trait in a
    fit pool (and there may be no way back)
  • Hopefully, a better understanding of microbial
    pathogenesis can lead to reduce antibiotic
    pressure
  • Have a happy day!

63
Additional References
  • Chang S, et al. Infection with
    vancomycin-resistant Staphylococcus aureus
    containing the vanA resistance gene. NEJM
    3481342, 2003.
  • De la Cruz F, and Davies J. Horizontal gene
    transfer and the origin of species lessons from
    bacteria. Trends Microbiol 8128, 2000.
  • Fluit AC and Schmitz F-J. Resistance integrons
    and superintegrons. Clin Microbiol Infect
    10272, 2004
  • Kazakova SV, et al. A clone of methicillin-resista
    nt Staphylococcus aureus among professional
    football players. NEJM 352468, 2005.
  • Levin B and Bergstrom C. Bacteria are different
    Observations, interpretations, speculations, and
    opinions about the mechanisms of adaptive
    evolution in prokaryotes. PNAS 976981, 2000.
  • Paulsen I, et al. Role of mobile DNA in the
    evolution of vancomycin-resistant Enterococcus
    faecalis. Science 2992071, 2003
  • Tenaillon O, et al. Mutators and sex in bacteria
    conflict between adaptive strategies. PNAS
    9710465, 2000.
Write a Comment
User Comments (0)
About PowerShow.com